今日肿瘤学最高分文献 - 2025-01-14 episode artwork

EPISODE · Jan 14, 2025 · 0 MIN

今日肿瘤学最高分文献 - 2025-01-14

from 萌喵读文献-肿瘤学 · host Meng Zhao

欢迎收听今日医学前沿!在最新的癌症治疗综述中,一项系统性回顾和元分析显示,Trastuzumab deruxtecan(T-DXd)在HER2阳性乳腺癌患者中展现出显著的治疗效果,特别是在脑转移和脑膜疾病。研究涵盖了18项研究,786名患者,结果显示60.4%的客观反应率、94.4%的疾病控制率和79.3%的临床获益率,以及12个月无进展生存率和总生存率分别为64.7%和82.7%。这为HER2阳性乳腺癌患者的中枢神经系统转移提供了新的治疗希望。不要错过这一突破性进展,深入了解T-DXd如何改变HER2阳性乳腺癌治疗的未来!

欢迎收听今日医学前沿!在最新的癌症治疗综述中,一项系统性回顾和元分析显示,Trastuzumab deruxtecan(T-DXd)在HER2阳性乳腺癌患者中展现出显著的治疗效果,特别是在脑转移和脑膜疾病。研究涵盖了18项研究,786名患者,结果显示60.4%的客观反应率、94.4%的疾病控制率和79.3%的临床获益率,以及12个月无进展生存率和总生存率分别为64.7%和82.7%。这为HER2阳性乳腺癌患者的中枢神经系统转移提供了新的治疗希望。不要错过这一突破性进展,深入了解T-DXd如何改变HER2阳性乳腺癌治疗的未来!

NOW PLAYING

今日肿瘤学最高分文献 - 2025-01-14

0:00 0:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of 萌喵读文献-肿瘤学?

This episode is 0 minutes long.

When was this 萌喵读文献-肿瘤学 episode published?

This episode was published on January 14, 2025.

What is this episode about?

欢迎收听今日医学前沿!在最新的癌症治疗综述中,一项系统性回顾和元分析显示,Trastuzumab...

Can I download this 萌喵读文献-肿瘤学 episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!